Viewing StudyNCT05722795



Ignite Creation Date: 2024-05-06 @ 6:36 PM
Last Modification Date: 2024-10-26 @ 2:51 PM
Study NCT ID: NCT05722795
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-02-10
First Post: 2022-04-11

Brief Title: Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer I-CONIC
Sponsor: Vastra Gotaland Region
Organization: Vastra Gotaland Region

Organization Data

Organization: Vastra Gotaland Region
Class: OTHER_GOV
Study ID: EudraCT 2020-005200-19
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Vastra Gotaland Region
Lead Sponsor Class: OTHER_GOV
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Lund University OTHER
Sahlgrenska University Hospital Sweden OTHER